On the way of tryptophan catabolism and the high activity of KMO in liver and kidney (Bertazzo, Ragazzi, & Biasiolo, 2001), KMO plays a very important role and has a definite regulatory effect on peripheral inflammation (Wilson et al., 2016) and central nervous system diseases. This evidence concerns the gene KMO and central nervous system disorder.